When presenting a treatment plan, when should the patient be told about all the risk, benefits, and treatment options?
after treatment has been completed
before they sign the pretreatment plan
after they sign the pretreatment plan
throughout the examination
before they sign the pretreatment plan
Rationale: before they sign the pretreatment plan – Before signing any treatment plan, the patient should have an understanding of what it is they are signing and assigning all the risk and benefits to treatment.
You might also like to view...
You respond to the scene of a vehicle accident and find a female patient standing outside her car complaining of neck pain. You should:
A) use a three-man carry to get her onto your gurney. B) use the stair chair to get her to the ambulance. C) apply a cervical collar and assist the patient into a sitting position. D) instruct the patient to lie flat on the ground so you can perform a direct lift.
The MCV on a patient is calculated to be 115 fL and the MCHC is 35 g/dL. What, in general terms, must be true of the MCH if it is consistent with the previous two indices?
a. It is impossible to know. b. It should be in the reference range. c. It should be below reference range. d. It should be above reference range.
The ________ Standard includes authorization and/or supervision, workforce clearance procedures, and termination procedures
A) Documentation B) Policies and Procedures C) Access Control D) Workforce Security E) Organizational Requirements
Which of the following is a skin inflammation that may be an allergic response to allergens, such as chemicals or foods?
A. Impetigo B. Herpes zoster C. Psoriasis D. Eczema E. Melanoma